Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Patritumab deruxtecan's trials
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Patritumab deruxtecan
Ongoing
Recruiting
Phase 3
Open NCT07060807 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
